Guangdong Xinhui Meida Nylon Past Earnings Performance
Past criteria checks 0/6
Guangdong Xinhui Meida Nylon's earnings have been declining at an average annual rate of -41.3%, while the Chemicals industry saw earnings growing at 8.4% annually. Revenues have been declining at an average rate of 1.5% per year.
Key information
-41.3%
Earnings growth rate
-38.3%
EPS growth rate
| Chemicals Industry Growth | 12.1% |
| Revenue growth rate | -1.5% |
| Return on equity | -7.3% |
| Net Margin | -4.5% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Guangdong Xinhui Meida Nylon makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 2,989 | -134 | 140 | 9 |
| 31 Dec 23 | 2,817 | -143 | 138 | 8 |
| 30 Sep 23 | 2,695 | -139 | 106 | 10 |
| 30 Jun 23 | 2,665 | -162 | 104 | 10 |
| 31 Mar 23 | 2,740 | -91 | 116 | 8 |
| 01 Jan 23 | 2,914 | -55 | 136 | 8 |
| 30 Sep 22 | 3,199 | 11 | 162 | 7 |
| 30 Jun 22 | 3,286 | 66 | 174 | 7 |
| 31 Mar 22 | 3,360 | 55 | 152 | 7 |
| 31 Dec 21 | 3,320 | 56 | 163 | 7 |
| 30 Sep 21 | 3,080 | 126 | 125 | 7 |
| 30 Jun 21 | 2,867 | 126 | 124 | 7 |
| 31 Mar 21 | 2,631 | 102 | 148 | 7 |
| 31 Dec 20 | 2,350 | 38 | 123 | 7 |
| 30 Sep 20 | 2,337 | 12 | 175 | 7 |
| 30 Jun 20 | 2,467 | -30 | 176 | 7 |
| 31 Mar 20 | 2,640 | -39 | 167 | 6 |
| 31 Dec 19 | 2,987 | 14 | 178 | 6 |
| 30 Sep 19 | 3,148 | -38 | 155 | 6 |
| 30 Jun 19 | 3,495 | 15 | 160 | 6 |
| 31 Mar 19 | 3,751 | 29 | 179 | 6 |
| 31 Dec 18 | 3,813 | 37 | 180 | 6 |
| 30 Sep 18 | 3,918 | 54 | 213 | 5 |
| 30 Jun 18 | 3,748 | 49 | 205 | 6 |
| 31 Mar 18 | 3,545 | 21 | 186 | 4 |
| 31 Dec 17 | 3,559 | 35 | 183 | 3 |
| 30 Sep 17 | 3,291 | -27 | 189 | 2 |
| 30 Jun 17 | 2,980 | -50 | 194 | 0 |
| 31 Mar 17 | 2,751 | -58 | 200 | 0 |
| 31 Dec 16 | 2,420 | -82 | 199 | 0 |
| 30 Sep 16 | 2,375 | -68 | 171 | 0 |
| 30 Jun 16 | 2,515 | -69 | 163 | 0 |
| 31 Mar 16 | 2,727 | 19 | 178 | 0 |
| 31 Dec 15 | 2,847 | 49 | 172 | 0 |
| 30 Sep 15 | 3,034 | -107 | 196 | 0 |
| 30 Jun 15 | 3,159 | -96 | 192 | 0 |
| 31 Mar 15 | 3,323 | -172 | 178 | 0 |
| 31 Dec 14 | 3,364 | -228 | 177 | 0 |
| 30 Sep 14 | 3,457 | -37 | 156 | 0 |
| 30 Jun 14 | 3,529 | -33 | 162 | 0 |
| 31 Mar 14 | 3,529 | -23 | 163 | 0 |
| 31 Dec 13 | 3,700 | 10 | 171 | 0 |
| 30 Sep 13 | 3,691 | 24 | 185 | 0 |
| 30 Jun 13 | 3,657 | 23 | 184 | 0 |
Quality Earnings: 000782 is currently unprofitable.
Growing Profit Margin: 000782 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 000782 is unprofitable, and losses have increased over the past 5 years at a rate of 41.3% per year.
Accelerating Growth: Unable to compare 000782's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 000782 is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-19.5%).
Return on Equity
High ROE: 000782 has a negative Return on Equity (-7.29%), as it is currently unprofitable.